Qualigens Pharma Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Qualigens Pharma Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $8.2M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Qualigens Pharma Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $8.2M Trade | TransData Nexus

Qualigens Pharma Private Limited

Indian Pharmaceutical Exporter · Analgesics & Antipyretics Specialist · $8.2M Total Trade · DGFT Verified

Qualigens Pharma Private Limited is an Indian pharmaceutical exporter with a total trade value of $8.2M across 3 products in 3 therapeutic categories. Based on 187 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ibuprofen ($5.6M), Simvastatin ($1.4M), Furosemide ($1.2M).

Qualigens Pharma Private Limited — Export Portfolio & Destination Treemap

Qualigens Pharma Private Limited pharmaceutical export portfolio — 3 products across 3 therapeutic categories. Source: Indian Customs (DGFT).

Who is Qualigens Pharma Private Limited? — Company Overview & Market Position

Qualigens Pharma Private Limited, established on October 10, 2013, is a privately held pharmaceutical company headquartered in Khalapur, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U24100MH2013PTC249071. As of the latest available data, Qualigens Pharma has an authorized capital of ₹2.00 crore and a paid-up capital of ₹1.55 crore. The company employs approximately 226 professionals, reflecting its commitment to quality and operational excellence.

Qualigens Pharma specializes in the manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's manufacturing facility is situated in a serene, dust-free, and pollution-free environment in Khopoli, Maharashtra, ensuring optimal conditions for pharmaceutical production. This facility has been accredited by several regulatory agencies, including EU-GMP, SAHPRA, Russian GMP, and WHO-GMP, underscoring its adherence to international quality standards.

What Does Qualigens Pharma Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Ibuprofen$5.6M 2

Product Portfolio — Top 3 by Export Value

Qualigens Pharma Private Limited exports 3 pharmaceutical products across 3 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Ibuprofen	Analgesics & Antipyretics	$5.6M	129	1.0%	14
2	Simvastatin	Cardiovascular	$1.4M	27	1.1%	11
3	Furosemide	Diuretics	$1.2M	31	1.8%	14

Qualigens Pharma Private Limited exports 3 pharmaceutical products across 3 therapeutic categories with a total export value of $8.2M. The top category is Analgesics & Antipyretics (68.4% of portfolio), followed by Cardiovascular (16.4%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Qualigens Pharma Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Qualigens Pharma's state-of-the-art manufacturing facility in Khopoli, Maharashtra, is designed to meet current Good Manufacturing Practice (cGMP) requirements. The plant boasts an annual capacity of over 4 billion tablets and 600 million capsules, catering to both niche complex molecules and high-volume generic products. The facility is equipped with high-end local and imported machinery to ensure quality by design (QbD) and defect-free products. Additionally, the plant has been accredited by several regulatory agencies, including EU-GMP, SAHPRA, Russian GMP, and WHO-GMP, reflecting its commitment to maintaining international quality standards.

3Key Leadership

The leadership team at Qualigens Pharma Private Limited comprises professionals with extensive experience in the pharmaceutical sector. Ajit Jain serves as a Director, bringing his expertise to the company's strategic direction. Aayush Jain, also a Director, holds qualifications in Chartered Accountancy (CA) and an MBA, contributing to the company's financial and operational strategies. Ankit Suresh Paharia, another Director, is a Chartered Accountant, adding to the financial acumen of the leadership team. These leaders, with over 30 years of combined experience, drive the company's mission to develop quality-assured generic and branded pharmaceutical products.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Qualigens Pharma Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Qualigens Pharma Private Limited has established a presence in several regulated markets, including the European Union (EU), South Africa, Russia, and other international markets. The company's manufacturing facility has been accredited by multiple regulatory agencies, such as EU-GMP, SAHPRA, Russian GMP, and WHO-GMP, indicating compliance with international quality standards. These accreditations facilitate market access and underscore the company's commitment to maintaining high-quality manufacturing practices.

In the United States, the company has achieved FDA certification, further expanding its reach in regulated markets. This certification reflects Qualigens Pharma's adherence to stringent manufacturing standards and its dedication to delivering quality pharmaceutical products globally.

2Emerging Markets

Qualigens Pharma Private Limited has successfully established its presence in emerging markets, particularly in Africa and Latin America. The company's manufacturing facility holds WHO-GMP certification, which is essential for accessing these markets. This certification enables Qualigens Pharma to supply quality-assured pharmaceutical products to regions where WHO prequalification is a prerequisite for market entry.

The company's strategic focus on emerging markets aligns with its mission to become a world pioneer in the healthcare segment by developing a wide range of quality-assured generic and branded pharmaceutical products. By leveraging its manufacturing capabilities and regulatory certifications, Qualigens Pharma aims to expand its footprint in these regions, contributing to global healthcare needs.

Qualigens Pharma Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Qualigens Pharma Private Limited has achieved FDA certification, indicating compliance with the stringent manufacturing standards set by the U.S. Food and Drug Administration. This certification reflects the company's commitment to quality and safety in pharmaceutical production. The FDA certification enhances the company's credibility and facilitates access to the U.S. market, a key destination for pharmaceutical exports.

The FDA certification process involves rigorous inspections and evaluations to ensure adherence to current Good Manufacturing Practices (cGMP). By obtaining this certification, Qualigens Pharma demonstrates its capability to meet the high standards required for pharmaceutical manufacturing in the United States. This achievement positions the company favorably for partnerships and collaborations with U.S.-based pharmaceutical companies and distributors.

2WHO & EU GMP

Qualigens Pharma Private Limited holds WHO-GMP certification, which is essential for accessing markets where WHO prequalification is a prerequisite for market entry. This certification underscores the company's commitment to maintaining high-quality manufacturing practices and ensures that its products meet international standards.

Additionally, the company's manufacturing facility is accredited with EU-GMP certification, reflecting compliance with the European Union's stringent manufacturing standards. This accreditation facilitates market access within the EU and demonstrates the company's dedication to quality and safety in pharmaceutical production.

Qualigens Pharma Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the pharmaceutical industry, Qualigens Pharma Private Limited faces competition from both domestic and international companies operating in similar therapeutic categories. The company's focus on finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, places it in competition with other manufacturers offering similar products. However, Qualigens Pharma's commitment to quality, as evidenced by its various certifications, provides a competitive edge in the market.

The company's strategic focus on both regulated and emerging markets allows it to tap into diverse customer bases, mitigating risks associated with market concentration. By leveraging its manufacturing capabilities and regulatory certifications, Qualigens Pharma positions itself as a competitive player in the global pharmaceutical market.

2Key Differentiators

Qualigens Pharma Private Limited distinguishes itself through its state-of-the-art manufacturing facility, which is accredited by multiple regulatory agencies, including EU-GMP, SAHPRA, Russian GMP, and WHO-GMP. This diverse range of certifications underscores the company's commitment to maintaining high-quality manufacturing practices and facilitates access to various international markets.

The company's focus on both niche complex molecules and high-volume generic products allows it to cater to a broad spectrum of market needs. Additionally, Qualigens

Frequently Asked Questions — Qualigens Pharma Private Limited

How many pharmaceutical products does Qualigens Pharma Private Limited export from India?

Qualigens Pharma Private Limited exports 3 pharmaceutical products across 3 therapeutic categories. The top exports are Ibuprofen ($5.6M), Simvastatin ($1.4M), Furosemide ($1.2M). Total export value is $8.2M.

What is Qualigens Pharma Private Limited's total pharmaceutical export value?

Qualigens Pharma Private Limited's total pharmaceutical export value is $8.2M, based on 187 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Qualigens Pharma Private Limited cover?

Qualigens Pharma Private Limited exports across 3 therapeutic categories. The largest are Analgesics & Antipyretics (68.4%, 1 products), Cardiovascular (16.4%, 1 products), Diuretics (15.2%, 1 products).

Get Full Qualigens Pharma Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.